Paris, June 30th, 2025 – Septodont, global leader in dental anesthesia, and Micro-Mega SA, a leading manufacturer of endodontics files, announce a commercial partnership for the distribution of the GenENDO, a range dedicated to endodontics, across Europe, the United Kingdom, the Middle East, and Africa.

Already recognized as a major player in endodontics, Septodont recently launched BioRoot™ Flow, a bioactive root canal sealer. The integration of the GenENDO range completes our portfolio with medical devices tailored to support different stages of endodontic treatment.*

GenENDO offers a concise yet comprehensive selection of high-quality endodontic files and motor, specifically designed to meet the needs of practitioners in canal shaping and preparation.

Micro-Mega and Septodont share a strong commitment to innovation, product quality, and a leading industrial presence in France.

About Septodont

Septodont, the global leader in dental anesthesia, is a family-owned mid-sized pharmaceutical company founded in 1932 by the Schiller family. The group develops, manufactures, and distributes a wide range of products and solutions dedicated to dental professionals worldwide. With 2,400 employees, the group operates in more than 110 countries. Beyond dentistry, through its Novocol Pharma division, the group also partners with pharmaceutical and medical device companies to provide contract manufacturing services for the filling and finishing of injectable pharmaceutical products. Learn more about Septodont’s innovative products and solutions at https://www.septodontcorp.com.

About COLTENE Micro-Mega

Founded in 1905, Micro-Mega SA has long been at the forefront of technical innovation and is globally recognized for its expertise in the design, manufacture, and marketing of medical devices for endodontics—including root canal instruments, obturation products, handpieces, and instrument hygiene solutions. The company became part of the COLTENE Group in 2018. From its facility in Besançon, Micro-Mega distributes its products across France and to 80 countries worldwide, through a network of over 250 authorized distributors. All production stages—from design to delivery—are housed under one roof, ensuring full control of the process along with optimized traceability and monitoring.

*Clinical efficacy of root canal treatment at 2 years using a new ready-to-use injectable calcium silicate-based sealer: A multicentric randomised controlled trial – International Endodontic Journal, 2025 June 10 – Stéphane Simon, Julien Beauquis, Hugues Colombel, Audrey Dorn, Valentin Marchi, Sébastien Robert, Grégoire Souleau, Nadia Ravalec, Florent Huguet-Jaime, Karine Chazaud, Anne-Laure Serandour, Nabila Ournid, Julian G. Leprince.